Microalbuminuria in hepatitis C-genotype 4: Effect of pegylated interferon and ribavirin

Table 1 Study subjects characteristics by HCV status

Characteristics	HCV status
	HCV-negative	HCV-positive
Age (yr)	46.0 (57.0)	46.0 (51.0)
Genderan (%)
Male	44 (18.4)	195 (81.6)
Female	23 (38.3)	37 (61.7)
Diabetes n (%)
No	31 (19.6)	127 (80.4)
Yes	32 (23.2)	106 (67.8)
Fibrosisan (%)
No/mild	67 (54.0)	57 (46)
Moderate/severe	0 (0.0)	137 (100)
Inflammationan (%)
No/mild	67 (100)	0 (0.0)
Moderate/severe	0 (0.0)	194 (100)
Body mass index (kg/m2)	27.9 (26.7)	29.2 (25.3)
Urea (mmol/L)	4.6 (41.4)	4.7 (128.9)
Creatinine (mg/dL)	75.0 (248.0)	77.0 (230.0)
ACR (mg/mmol)	1 (36.8)	1 (193.9)
eGFR (mL/min every 1.73 m2)	99.5 (317.0)	98.0 (155.0)
Microalbuminuriaab (µg/mg)	5.9 (299.0)	9.5 (399.0)
ALTab (U/L)	25.0 (110.0)	66.0 (583.0)
Hemoglobinab (g/dL)	14.0 (7.0)	14.9 (9.5)

^aP < 0.05;

^bKruskal-Wallis test. HCV: Hepatitis C virus; ACR: Albumin creatinine ratio; eGFR: Estimated glomerular filtration rate; ALT: Alanine aminotransferase. Quantities given as median (range).